Market Tracker

10/31 7:05pm ET

Oramed Pharmaceuticals Inc (NASDAQ:ORMP)

7.18
Data as of Oct 31
 -0.22 / -2.97%
Today’s Change
6.28
Today|||52-Week Range
31.73
-53.47%
Year-to-Date
No recent news for Oramed Pharmaceuticals Inc.

Today’s Trading

Previous close7.40
Today’s open7.45
Day’s range7.05 - 7.69
Volume51,787
Average volume (3 months)47,133
Market cap$73.7M
Dividend yield--
Data as of 3:59pm ET, 10/31/2014

Growth & Valuation

Earnings growth (last year)+1.67%
Earnings growth (this year)--
Earnings growth (next 5 years)--
Revenue growth (last year)--
P/E ratioNM
Price/Sales--
Price/Book7.22

Competitors

 Today’s
change
Today’s
% change
ARQLArQule Inc-0.02-1.71%
GLMDGalmed Pharmaceutica...-0.05-0.75%
CNDOCoronado Biosciences...+0.04+2.35%
CYCCCyclacel Pharmaceuti...-0.11-3.29%
Data as of 3:59pm ET, 10/31/2014

Financials

Last reporting dateOctober 29, 2014
EPS forecast (this quarter)-$0.19
Annual revenue (last year)$0.00
Annual profit (last year)-$4.2M
Net profit margin--

Profile

Sector
Health Technology
Industry
Pharmaceuticals: Other
President, Chief Executive Officer &
Director
Nadav Kidron
Chief Operating Officer &
VP-Business Development
Joshua Hexter
Corporate headquarters
Jerusalem, --

Forecasts